文献速递精神分裂症与精神病性障碍

首发精神病队列的多模态研究:抗精神病药治疗抵抗的潜在标志物

A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance.
PubMed 文献 · Mol Psychiatry · 2021-10-12

该研究纳入136例首发精神病患者,分析人口学、临床、脑结构及7T磁共振波谱分子影像数据,控制年龄、性别、种族、吸烟、病程和抗精神病药剂量。发现治疗抵抗患者起病年龄更小、住院次数更多、阴性症状更重,海马与额上回体积减小,前扣带回谷胱甘肽水平降低;多标志物联合分类优于单一标志物。

要点

  • 治疗抵抗患者起病年龄更小、住院更多、阴性症状更重。
  • 治疗抵抗患者海马和额上回体积减小,前扣带回谷胱甘肽降低。
  • 多标志物联合对治疗抵抗与非治疗抵抗的分类优于单一标志物。

核心结论

  • 前扣带回谷胱甘肽、海马和额上回体积及起病年龄可能作为治疗抵抗诊断的潜在生物标志物。
  • 住院次数和阴性症状可能用于评估疾病进展。
  • 多模态队列对全面理解脑疾病至关重要。

研究设计与样本

  • 研究分析136例首发精神病患者的人口学、临床、脑结构成像及7T磁共振波谱分子成像数据。
  • 分析中控制了年龄、性别、种族、吸烟状态、病程和抗精神病药剂量。

主要发现

  • 治疗抵抗患者较非治疗抵抗患者起病年龄更小、住院次数更多、阴性症状更严重。
  • 治疗抵抗患者海马和额上回体积减小。
  • 治疗抵抗患者前扣带回谷胱甘肽水平降低。
  • 多标志物联合对治疗抵抗与非治疗抵抗的分类优于任何单一标志物。

临床怎么用

  • 前扣带回谷胱甘肽、海马和额上回体积及起病年龄可能辅助识别治疗抵抗。
  • 住院次数和阴性症状可用于评估疾病进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Treatment resistant (TR) psychosis is considered to be a significant cause of disability and functional impairment. Numerous efforts have been made to identify the clinical predictors of TR. However, the exploration of molecular and biological markers is still at an early stage. To understand the TR condition and identify potential molecular and biological markers, we analyzed demographic information, clinical data, structural brain imaging data, and molecular brain imaging data in 7 Tesla magnetic resonance spectroscopy from a first episode psychosis cohort that includes 136 patients. Age, gender, race, smoking status, duration of illness, and antipsychotic dosages were controlled in the analyses. We found that TR patients had a younger age at onset, more hospitalizations, more severe negative symptoms, a reduction in the volumes of the hippocampus (HP) and superior frontal gyrus (SFG), and a reduction in glutathione (GSH) levels in the anterior cingulate cortex (ACC), when compared to non-TR patients. The combination of multiple markers provided a better classification between TR and non-TR patients compared to any individual marker. Our study shows that ACC-GSH, HP and SFG volumes, and age at onset, could potentially be biomarkers for TR diagnosis, while hospitalization and negative symptoms could be used to evaluate the progression of the disease. Multimodal cohorts are essential in obtaining a comprehensive understanding of brain disorders.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Yang K, Longo L, Narita Z, et al. A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance. Mol Psychiatry. 2021. PMID: 34642460. doi:10.1038/s41380-021-01331-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。